Cite
HARVARD Citation
Bsteh, G. et al. (2017). Discontinuation of disease-modifying therapies in multiple sclerosis – Clinical outcome and prognostic factors. Multiple sclerosis. pp. 1241-1248. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bsteh, G. et al. (2017). Discontinuation of disease-modifying therapies in multiple sclerosis – Clinical outcome and prognostic factors. Multiple sclerosis. pp. 1241-1248. [Online].